
- Growth Performance of Top 50 Companies in IPM (MAT Dec’24)
The top 50 pharmaceutical companies in the Indian Pharmaceutical Market (IPM) have grown significantly in various zones (West, South, North, and East). The following key insights emerge:
• The top 30 cities contributed 34% to IPM Sales for MAT Dec’24.
• The top cities grew at 8.5%, slightly higher than the overall IPM growth of 7.6%.
• Among mega metros, Delhi was the fastest-growing at 12.5%, followed by Chennai (11.6%) and Hyderabad (10.5%).
• Fastest-growing cities: Pune, Agra, Lucknow, Nashik, and Delhi saw the highest growth in demand.
• 13 out of the top 30 metros grew faster than the overall IPM, while 17 metros had growth equal to or lower than 7.6%.
• Reliance Life Sciences, Fresenius Kabi, and Merck Specialities were the fastest-growing in different regions, with growth rates exceeding 30-40%.
- Top 20 Fastest-Growing Companies by Zone
Each region showed distinct trends in terms of growth and key players:
• West Zone: AstraZeneca (28.6%), La Renon Healthcare (23.0%), Samarth Pharma (20.8%)
• South Zone: Reliance Life Sciences (47.6%), Fresenius Kabi (42.3%), Merck Specialities (30.9%)
• North Zone: AstraZeneca (37.7%), Bayer Pharma (33.9%), Aareen Healthcare (28.7%)
• East Zone: Hetero Healthcare (19.4%), Natco Pharma (18.9%), Corona Remedies (14.8%)





